Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2 alpha.
Prostaglandin F2alpha (PGF2alpha) has been recognized as the physiological luteolysin in ruminants and other species for more than three decades; however, the mechanisms involved in its action are poorly understood. We previously have shown that endothelin-1 (ET-1) mediates, at least in part, the action of PGF2alpha, and the current study examines the effect of PGF2alpha on the expression of ET-1 in bovine corpus luteum (CL). Endothelins (ETs) were extracted from CL, collected at various times of the estrous cycle, and highest levels were found during luteolysis. The expression of prepro-ET-1 was also highest in regressing CL, suggesting that PGF2alpha may have elevated ET-1 expression. This was confirmed by demonstrating that administration of PGF2alpha to heifers at midcycle elevated luteal ET-1 expression. Levels were induced as soon as 2 h after PGF2alpha treatment and 24 h later were 7-fold higher than preinjection levels. Endothelial cells isolated from bovine CL produced ET-1, and addition of PGF2alpha, oxytocin (OT), and vasopressin-augmented ET biosynthesis. Induction of ET-1 expression by PGF2alpha in these cells was evident after a short incubation time (15-90 min). Taken together, these data suggest that stimulation of luteal ET-1 expression by PGF2alpha may be achieved by several nonmutually exclusive mechanisms: 1) by acting directly on luteal endothelial cells; 2) indirectly, via OT release from large luteal cells; and 3) by causing hypoxia in the CL (as a result of ET-1-induced vasoconstriction). The latter mechanism may serve to augment ET-1 secretion in a positive-feedback process.
Girsh
E
E
Department of Animal Science, Section of Reproduction, The Hebrew University of Jerusalem, Rehovot, Israel.
Wang
W
W
Mamluk
R
R
Arditi
F
F
Friedman
A
A
Milvae
R A
RA
Meidan
R
R
D000818:Animals; D001808:Blood Vessels / Q000378:metabolism; D002417:Cattle; D003338:Corpus Luteum / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D015237:Dinoprost / Q000494:pharmacology*; D019332:Endothelin-1 / Q000235:genetics / Q000378:metabolism*; D004971:Estrus; D005260:Female; D066298:In Vitro Techniques; D008833:Microcirculation; D012333:RNA, Messenger / Q000378:metabolism
D019332:Endothelin-1; D012333:RNA, Messenger; D015237:Dinoprost